The surgical treatment of type II diabetes mellitus: changes in HOMA Insulin resistance in the first year following laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB)
- PMID: 19629603
- DOI: 10.1007/s11695-009-9870-2
The surgical treatment of type II diabetes mellitus: changes in HOMA Insulin resistance in the first year following laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB)
Abstract
Background: Bariatric operations significantly improve glucose metabolism, decrease insulin resistance, and lead to clinical resolution of type II diabetes mellitus in many patients. The mechanisms that achieve these clinical outcomes, however, remain ill defined. Moreover, the relative impact of various operations on insulin resistance remains vigorously contested. Consequently, the purpose of this study was to compare directly the impact of laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB) on hemoglobin A1c (HbA1c) levels and insulin resistance in comparable groups of morbidly obese patients.
Methods: Data were entered prospectively into our bariatric surgery database and reviewed retrospectively. Patients selected operations. Principle outcome variables were percent excess weight loss (%EWL), HbA1c, and homeostatic model assessment for insulin resistance (HOMA IR).
Results: The number of follow-up visits for 111 LAGB patients was 263 with a median of 162 days (17-1,016) and 291 follow-up visits for 104 LRYGB patients for a median of 150 days (8-1,191). Preoperative height, weight, body mass index, age, sex, race, comorbidities, fasting glucose, insulin, HbA1c, and HOMA IR were similar for both groups. In particular, the number of patients who were diabetics and those receiving insulin and other hypoglycemic agents were similar among the two groups. The LAGB patients lost significantly less weight than the LRYGB patients (24.6% compared to 44.0% EWL). LAGB reduced HbA1c from 5.8% (2-13.8) to 5.6% (0.3-12.3). LRYGB reduced HbA1c from 5.9% (2.0-12.3) to 5.4% (0.1-9.8). LAGB reduced HOMA IR from 3.6 (0.8-39.2) to 2.3 (0-55) and LRYGB reduced HOMA IR from 4.4 (0.6-56.5) to 1.4 (0.3-15.2). Postoperative HOMA IR correlated best with %EWL. Indeed, regression equations were essentially identical for LAGB and LRYGB for drop in %EWL versus postoperative HOMA IR.
Conclusion: Percent excess weight loss significantly predicts postoperative insulin resistance (HOMA IR) during the first year following both LRYGB and LAGB.
Similar articles
-
Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass.Obes Surg. 2006 Sep;16(9):1189-97. doi: 10.1381/096089206778392158. Obes Surg. 2006. PMID: 16989703
-
Outcomes of laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding in adolescents.Obes Surg. 2012 Dec;22(12):1859-64. doi: 10.1007/s11695-012-0742-9. Obes Surg. 2012. PMID: 22923312
-
Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States.Surg Endosc. 2012 Jul;26(7):1909-19. doi: 10.1007/s00464-011-2125-z. Epub 2012 Jan 5. Surg Endosc. 2012. PMID: 22219011
-
Laparoscopic Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Nonseverely Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Obes Surg. 2020 May;30(5):1660-1670. doi: 10.1007/s11695-019-04378-2. Obes Surg. 2020. PMID: 31912466
-
Short-Term Outcomes of Conversion of Failed Gastric Banding to Laparoscopic Sleeve Gastrectomy or Roux-En-Y Gastric Bypass: a Meta-Analysis.Obes Surg. 2019 Feb;29(2):420-425. doi: 10.1007/s11695-018-3538-8. Obes Surg. 2019. PMID: 30293135
Cited by
-
Quality of life parameters, weight change and improvement of co-morbidities after laparoscopic Roux Y gastric bypass and laparoscopic gastric sleeve resection--comparative study.Obes Surg. 2011 Mar;21(3):288-94. doi: 10.1007/s11695-010-0227-7. Obes Surg. 2011. PMID: 20628831
-
Twelve year experience of laparoscopic gastric plication in morbid obesity: development of the technique and patient outcomes.Ann Surg Innov Res. 2012 Aug 22;6(1):7. doi: 10.1186/1750-1164-6-7. Ann Surg Innov Res. 2012. PMID: 22913751 Free PMC article.
-
Defining and predicting complete remission of type 2 diabetes: a short-term efficacy study of open gastric bypass.Obes Facts. 2013;6(2):176-84. doi: 10.1159/000351018. Epub 2013 Apr 12. Obes Facts. 2013. PMID: 23594442 Free PMC article. Clinical Trial.
-
Bariatric surgery as treatment for type 2 diabetes.Curr Diab Rep. 2010 Aug;10(4):261-3. doi: 10.1007/s11892-010-0118-2. Curr Diab Rep. 2010. PMID: 20440583 No abstract available.
-
Predictors of short-term diabetes remission after laparoscopic Roux-en-Y gastric bypass.Obes Surg. 2015 May;25(5):782-7. doi: 10.1007/s11695-014-1477-6. Obes Surg. 2015. PMID: 25361763 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials